BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,152 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,665,810 | +6.2% | 49,800 | +19.8% | 0.01% | -28.6% |
Q3 2023 | $1,568,437 | -47.1% | 41,559 | -36.1% | 0.01% | -46.2% |
Q2 2023 | $2,965,273 | +2832.5% | 65,085 | +2510.7% | 0.01% | +1200.0% |
Q1 2023 | $101,116 | -76.1% | 2,493 | -70.0% | 0.00% | -50.0% |
Q4 2022 | $423,765 | -61.4% | 8,314 | -59.2% | 0.00% | -60.0% |
Q3 2022 | $1,098,000 | +290.7% | 20,383 | +366.4% | 0.01% | +400.0% |
Q2 2022 | $281,000 | -93.5% | 4,370 | -92.2% | 0.00% | -93.3% |
Q1 2022 | $4,351,000 | +73.8% | 56,112 | +92.5% | 0.02% | +200.0% |
Q4 2021 | $2,503,000 | +7.3% | 29,156 | +0.5% | 0.01% | -16.7% |
Q3 2021 | $2,332,000 | -81.7% | 29,000 | -81.6% | 0.01% | -78.6% |
Q2 2021 | $12,717,000 | +693.8% | 157,978 | +731.5% | 0.03% | +600.0% |
Q1 2021 | $1,602,000 | +0.6% | 19,000 | -4.2% | 0.00% | 0.0% |
Q4 2020 | $1,592,000 | +4.2% | 19,842 | +4.4% | 0.00% | -63.6% |
Q3 2020 | $1,528,000 | -6.6% | 19,000 | 0.0% | 0.01% | -15.4% |
Q2 2020 | $1,636,000 | +8510.5% | 19,000 | +7916.9% | 0.01% | – |
Q1 2020 | $19,000 | -99.7% | 237 | -99.6% | 0.00% | -100.0% |
Q4 2019 | $5,493,000 | – | 65,694 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |